药明康德(02359)_个股概要_股票价格_最新资讯_行情走势_历史数据 - 老虎社区

应交易所要求，美/港股行情延时15分钟展示，下载APP即可免费查看实时行情。

关闭

02359 药明康德

未开盘 07-06 16:08:32

155.500

-0.600

-0.38%

最高161.300	最低154.700	成交量658.24万
今开156.500	昨收156.100	日振幅4.23%
总市值4,609亿	流通市值761.95亿	总股本29.64亿
成交额10.35亿	换手率1.34%	流通股本4.90亿
市净率--	ROE--	每股收益0.00
52周最高--	52周最低--	市盈率--
股息--	股息收益率--	ROA--

数据加载中...

北京优虎网络科技有限公司

免责声明:香港交易所资讯服务有限公司、其控股公司及／或该等控股公司的任何附属公司均竭力确保所提供信息的准确和可靠度，但不能保证其绝对准确和可靠，且亦不会承担因任何不准确或遗漏而引起的任何损失或损害的责任（不管是否侵权法下的责任或合约责任又或其它责任）

{"stockData":{"symbol":"02359","market":"HK","secType":"STK","nameCN":"药明康德","latestPrice":155.5,"timestamp":1783325312005,"preClose":156.1,"halted":0,"volume":6582377,"delay":0,"changeRate":-0.0038436899423446146,"floatShares":490000000,"shares":2964000000,"eps":7.630145251484279,"marketStatus":"未开盘","change":-0.6,"latestTime":"07-06 16:08:32","open":156.5,"high":161.3,"low":154.7,"amount":1035470418,"amplitude":0.042281,"askPrice":155.6,"askSize":14400,"bidPrice":155.5,"bidSize":12600,"shortable":3,"etf":0,"ttmEps":7.968665129918513,"tradingStatus":0,"nextMarketStatus":{"tag":"开盘","tradingStatus":2,"beginTime":1783387800000},"marketStatusCode":0,"adr":0,"listingDate":1544630400000,"exchange":"SEHK","adjPreClose":156.1,"dividendRate":0.014383,"openAndCloseTimeList":[[1783301400000,1783310400000],[1783314000000,1783324800000]],"volumeRatio":0.8041672634658293,"lotSize":100,"spreadScale":0,"tradeCurrency":"HKD","optionSymbol":"WXA.HK","astockBrief":{"symbol":"603259","market":"SH","secType":"STK","nameCN":"药明康德","latestPrice":122.97,"timestamp":1783321200000,"preClose":124.12,"halted":0,"volume":92169700,"delay":0,"premium":"+9.55"},"impliedVol":0.5109,"impliedVolPercentile":0.9369},"requestUrl":"/m/hq/s/02359/tweets","defaultTab":"tweets","newsList":[{"id":"2649206625","title":"摩根大通增持药明康德(02359.HK)约236.85万股 每股作价约155.71港元","url":"https://stock-news.laohu8.com/highlight/detail?id=2649206625","media":"智通财经","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2649206625?lang=zh_cn&edition=full","pubTime":"2026-07-06 18:55","pubTimestamp":1783335319,"startTime":"0","endTime":"0","summary":null,"market":"hk","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://www.zhitongcaijing.com/immediately.html?type=ganggu","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"live_zhitongcaijing","symbols":["LU0052750758.USD","BK1576","LU0348766576.USD","02359","LU0708995583.HKD","LU1046422090.SGD","BK1583","LU0320764599.SGD","LU0348767384.USD","BK1141","LU2242644610.SGD","LU2045819591.USD","LU2125910500.SGD"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"1110056813","title":"异动解读｜药明康德盘中上涨3.14%，CXO板块集体走强叠加大行上调目标价","url":"https://stock-news.laohu8.com/highlight/detail?id=1110056813","media":"行情直击","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/1110056813?lang=zh_cn&edition=full","pubTime":"2026-07-06 10:21","pubTimestamp":1783304500,"startTime":"0","endTime":"0","summary":"7月6日，药明康德盘中上涨3.14%，报161.0港元，成交额2.99亿港元。消息面上，生命科学工具和服务板块集体走强，药明合联涨5.83%、晶泰控股涨5.95%、金斯瑞生物科技涨5.95%。此前摩根士丹利将药明康德H股目标价由155港元上调至168港元，重申为\"首选股\"，并将公司2026至2028年调整后盈利预测上调4%至6%，预期年复合增长率达16%。此外，公司已完成10亿元A股回购及25亿港元H股回购计划，回购股份用于员工持股计划，彰显管理层对公司价值的信心。（以上内容均基于市场公开消息，由程序或算法智能生成，仅作为股价异动提醒，不作为投资建议或交易依据。）","market":"hk","thumbnail":"","type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["02359"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2649213691","title":"每周股票复盘：药明康德（603259）回购A股用于员工持股计划","url":"https://stock-news.laohu8.com/highlight/detail?id=2649213691","media":"证券之星","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2649213691?lang=zh_cn&edition=full","pubTime":"2026-07-05 01:06","pubTimestamp":1783184772,"startTime":"0","endTime":"0","summary":"截至2026年7月3日收盘，药明康德报收于124.12元，较上周的118.18元上涨5.03%。本周，药明康德7月2日盘中最高价报129.15元，股价触及近一年最高点。药明康德当前最新总市值3703.44亿元，在医疗服务板块市值排名1/51，在两市A股市值排名40/5203。股本股东变化：期内回购16,187,300股H股及9,701,1231股A股，A股回购用于员工持股计划。H股公告显示，截至2026年6月30日，公司H股和A股的法定注册资本无变动，总注册资本为人民币2,983,757,155元。","market":"sh","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://stock.stockstar.com/RB2026070500000093.shtml","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"stockstar","symbols":["LU0348767384.USD","02359","LU2045819591.USD","LU1770034418.SGD","LU2242644610.SGD","IE00B5MMRT66.SGD","BK1141","LU0611395673.USD","603259","LU1979443071.USD","LU1251922891.USD","LU0348766576.USD","LU1303224171.USD","BK1576","LU1808992512.USD","LU2495084118.USD","BK0216","LU0320764599.SGD","IE00BPRC5H50.USD","399300","159982","LU0708995583.HKD","LU1969619763.USD","LU1997245177.USD","LU1997245094.SGD","LU1934453819.USD","LU1997244956.HKD","IE00B543WZ88.USD","LU2328871848.SGD","BK1583","LU0052750758.USD","LU2488822045.USD","LU1719994722.HKD","LU1046422090.SGD","LU0456842615.SGD","LU2125910500.SGD"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2648317661","title":"药明康德（603259）披露股份回购及可转债相关情况，7月3日股价上涨2.32%","url":"https://stock-news.laohu8.com/highlight/detail?id=2648317661","media":"证券之星","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2648317661?lang=zh_cn&edition=full","pubTime":"2026-07-03 22:01","pubTimestamp":1783087311,"startTime":"0","endTime":"0","summary":"截至2026年7月3日收盘，药明康德报收于124.12元，较前一交易日上涨2.32%，最新总市值为3703.44亿元。该股当日开盘123.6元，最高125.06元，最低119.52元，成交额达87.54亿元，换手率为2.88%。近日，无锡药明康德新药开发股份有限公司披露证券变动月报表。截至2026年6月30日，公司H股和A股的法定注册资本无变动，总注册资本为人民币2,983,757,155元。期内，公司回购16,187,300股H股及9,701,231股A股，均作为库存股份持有。其中A股回购用于员工持股计划。","market":"fut","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://stock.stockstar.com/RB2026070300045096.shtml","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"stockstar","symbols":["LU1997244956.HKD","LU0348767384.USD","BK1141","LU1303224171.USD","LU2488822045.USD","LU2495084118.USD","BK0216","LU2125910500.SGD","LU1969619763.USD","LU1808992512.USD","LU2045819591.USD","LU1046422090.SGD","IE00BPRC5H50.USD","LU1979443071.USD","BK1583","LU0708995583.HKD","LU1997245177.USD","IE00B543WZ88.USD","LU1251922891.USD","LU1770034418.SGD","LU1719994722.HKD","LU0348766576.USD","LU0052750758.USD","LU2242644610.SGD","LU1934453819.USD","LU0320764599.SGD","LU0611395673.USD","02359","LU0456842615.SGD","LU1997245094.SGD","603259","LU2328871848.SGD","BK1576","IE00B5MMRT66.SGD"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"1148233046","title":"药明康德发布2026年6月股份变动月报，回购H股16,187,300股与A股9,701,231股","url":"https://stock-news.laohu8.com/highlight/detail?id=1148233046","media":"公告速递","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/1148233046?lang=zh_cn&edition=full","pubTime":"2026-07-03 16:33","pubTimestamp":1783067626,"startTime":"0","endTime":"0","summary":"报告期为2026年6月1日至6月30日，公司已发行股本情况如下：H股于月底实收股本总数为510,476,909股，其中490,328,009股为已发行股份、20,148,900股为库存股份；A股于月底实收股本总数为2,473,280,246股，其中2,463,579,015股为已发行股份、9,701,231股为库存股份。公司注册股本合计为2,983,757,155股。报告期内，药明康德于2026年6月1日至6月16日期间回购H股16,187,300股并持作库存；6月11日至6月25日期间回购A股9,701,231股并同样持作库存，所回购A股将用于员工持股计划；未有新增发行或股份注销事项。","market":"us","thumbnail":"","type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["02359"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2648578018","title":"【特约大V】邓声兴：美第三季度开局不利，恒指或随外围走低","url":"https://stock-news.laohu8.com/highlight/detail?id=2648578018","media":"金吾财讯","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2648578018?lang=zh_cn&edition=full","pubTime":"2026-07-02 09:45","pubTimestamp":1782956725,"startTime":"0","endTime":"0","summary":"国指跌47点或0.62%，报7558点。科指升79点或1.8%，报4472点。美第三季度开局不利，恒指或随外围走低。小分子D&M业务收入69.3亿元，按年激增80.1%，创单季历史新高；TIDES业务收入23.8亿元，客户数与服务分子数分别按年提升28%及59%，公司预计全年TIDES收入增长约40%。截至3月底，持续经营业务在手订单达597.7亿元，按年增长23.6%，为未来增长奠定坚实基础。考虑到公司CRDMO龙头地位、小分子D&M强劲增长及TIDES业务爆发潜力，估值仍具向上修复空间。","market":"hk","thumbnail":"https://static.szfiu.com/news/20241108/NmQyMzI4NWZmMGRlNDRmMTg4YmIyOTUwMDI3OTAzODMzODA5NjYxNDI=.jpg","type":0,"news_type":0,"thumbnails":["https://static.szfiu.com/news/20241108/NmQyMzI4NWZmMGRlNDRmMTg4YmIyOTUwMDI3OTAzODMzODA5NjYxNDI=.jpg"],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"1984931","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["LU1046422090.SGD","LU0052750758.USD","03952","BK1583","HSI","03419","513600","LU2242644610.SGD","LU2045819591.USD","LU0708995583.HKD","07300","LU0348766576.USD","03037","LU0320764599.SGD","06715","07200","HSTECH","82800","LU2125910500.SGD","09115","06915","603259","02359","MCHmain","BK1141","02697","07500","03115","BK1576","83115","02833","LU0348767384.USD","02800","HHImain"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2648549686","title":"药明康德（603259）披露关于更换公司秘书的议案，7月1日股价上涨0.55%","url":"https://stock-news.laohu8.com/highlight/detail?id=2648549686","media":"证券之星","labels":["executive"],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2648549686?lang=zh_cn&edition=full","pubTime":"2026-07-01 22:02","pubTimestamp":1782914539,"startTime":"0","endTime":"0","summary":"截至2026年7月1日收盘，药明康德报收于125.2元，较前一交易日上涨0.55%，最新总市值为3735.66亿元。该股当日开盘123.0元，最高126.66元，最低115.58元，成交额达135.55亿元，换手率为4.55%。近日，无锡药明康德新药开发股份有限公司披露第四届董事会第四次会议决议公告。会议审议通过《关于更换公司秘书的议案》，表决结果为11票赞成，0票反对，0票弃权。","market":"hk","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://stock.stockstar.com/RB2026070100043234.shtml","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"executive","news_rank":0,"length":0,"strategy_id":0,"source":"stockstar","symbols":["LU1808992512.USD","BK0216","LU1969619763.USD","LU0348767384.USD","LU2125910500.SGD","LU2488822045.USD","LU1934453819.USD","LU1046422090.SGD","LU0052750758.USD","LU2045819591.USD","LU0611395673.USD","BK1583","IE00B543WZ88.USD","LU1997244956.HKD","LU0320764599.SGD","LU1303224171.USD","LU1770034418.SGD","LU1997245177.USD","603259","LU2242644610.SGD","LU2328871848.SGD","LU1251922891.USD","LU0708995583.HKD","LU0348766576.USD","IE00BPRC5H50.USD","02359","IE00B5MMRT66.SGD","BK1141","BK1576","LU1997245094.SGD","LU2495084118.USD","LU0456842615.SGD","LU1719994722.HKD","LU1979443071.USD"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2648548925","title":"药明康德：第四届董事会第四次会议决议公告","url":"https://stock-news.laohu8.com/highlight/detail?id=2648548925","media":"证券日报","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2648548925?lang=zh_cn&edition=full","pubTime":"2026-07-01 19:50","pubTimestamp":1782906600,"startTime":"0","endTime":"0","summary":"证券日报网讯7月1日，药明康德发布公告称，公司第四届董事会第四次会议审议通过《关于更换公司秘书的议案》。","market":"hk","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"http://finance.eastmoney.com/a/202607013790452120.html","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"stock_eastmoney","symbols":["603259","LU1770034418.SGD","LU1934453819.USD","LU0320764599.SGD","LU1997245177.USD","LU2125910500.SGD","LU1046422090.SGD","IE00B543WZ88.USD","LU0611395673.USD","BK1576","LU2495084118.USD","LU0456842615.SGD","02359","LU2488822045.USD","LU1251922891.USD","IE00B5MMRT66.SGD","LU2045819591.USD","LU0348766576.USD","LU2242644610.SGD","LU1303224171.USD","LU1719994722.HKD","LU1997244956.HKD","LU1979443071.USD","LU0708995583.HKD","LU1997245094.SGD","LU0052750758.USD","LU2328871848.SGD","LU1969619763.USD","LU1808992512.USD","BK1583","BK1141","IE00BPRC5H50.USD","BK0216","LU0348767384.USD"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2648251497","title":"药明康德(02359)：杨小慧获委任为公司秘书及法律程序文件代理人","url":"https://stock-news.laohu8.com/highlight/detail?id=2648251497","media":"智通财经","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2648251497?lang=zh_cn&edition=full","pubTime":"2026-07-01 18:15","pubTimestamp":1782900948,"startTime":"0","endTime":"0","summary":"智通财经APP讯，药明康德(02359)发布公告，卓佳专业商务有限公司(Vistra卓佳集团成员公司)公司秘书服务董事张月芬女士(张女士)已退休离任本公司其中一名公司秘书(公司秘书);及根据香港联合交易所有限公司证券上市规则第19A.13(2)条项下及香港法例第622章公司条例第16部在香港代表本公司接受送达法律程序文件及通知书的代理人(法律程序文件代理人)，自2026年7月1日起生效。本公司董事会进一步宣布，杨小慧女士(杨女士)已获委任接替张女士，自2026年7月1日起生效。其将与韩敏女士一起共同担任公司秘书及法律程序文件代理人，处理召集公司会议及秘书事务等日常公司治理事项。","market":"sh","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"http://www.zhitongcaijing.com/content/detail/1461896.html","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"stock_zhitongcaijing","symbols":["LU1934453819.USD","LU1997245094.SGD","LU2328871848.SGD","LU0348766576.USD","LU2488822045.USD","LU1770034418.SGD","LU1251922891.USD","LU1997245177.USD","LU1997244956.HKD","LU0320764599.SGD","LU1046422090.SGD","IE00BPRC5H50.USD","BK1576","LU1808992512.USD","LU2125910500.SGD","BK0216","LU0708995583.HKD","IE00B5MMRT66.SGD","LU1969619763.USD","LU1979443071.USD","603259","IE00B543WZ88.USD","LU0611395673.USD","LU0052750758.USD","LU0348767384.USD","LU1303224171.USD","LU2495084118.USD","BK1583","BK1141","LU2045819591.USD","LU1719994722.HKD","LU0456842615.SGD","LU2242644610.SGD","02359"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"1134039316","title":"摩根大通对药明康德H股空头头寸增至3.03%","url":"https://stock-news.laohu8.com/highlight/detail?id=1134039316","media":"美股速递","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/1134039316?lang=zh_cn&edition=full","pubTime":"2026-06-30 17:50","pubTimestamp":1782813046,"startTime":"0","endTime":"0","summary":"香港交易所数据显示，截至6月24日，摩根大通对药明康德H股的空头持仓比例已从之前的2.29%显著上升至3.03%。这一变动反映了市场参与者对该股后市走势的看空情绪有所加剧。空头头寸的增加通常意味着机构投资者预期股价可能下跌，并通过借入股票卖出的方式寻求获利。","market":"us","thumbnail":"","type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"-1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["IE00BPRC5H50.USD","603259","LU1046422090.SGD","LU1251922891.USD","LU1969619763.USD","LU1997245094.SGD","LU2495084118.USD","LU0348766576.USD","LU0052750758.USD","LU2045819591.USD","LU1997245177.USD","LU0456842615.SGD","LU1934453819.USD","LU1303224171.USD","IE00B5MMRT66.SGD","IE00B543WZ88.USD","LU0320764599.SGD","LU0348767384.USD","02359","LU0708995583.HKD","LU2125910500.SGD","BK1141","LU1997244956.HKD","BK1576","LU2488822045.USD","BK0216","BK1583","LU1979443071.USD","LU1770034418.SGD","LU2242644610.SGD","LU1719994722.HKD","LU2328871848.SGD","LU1808992512.USD"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2647395015","title":"药明康德：已启动并顺利完成了A股股份回购工作","url":"https://stock-news.laohu8.com/highlight/detail?id=2647395015","media":"证券之星","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2647395015?lang=zh_cn&edition=full","pubTime":"2026-06-30 17:03","pubTimestamp":1782810197,"startTime":"0","endTime":"0","summary":"证券之星消息，药明康德06月30日在投资者关系平台上答复投资者关心的问题。谢谢药明康德回复：您好，感谢您对公司的关注。截至目前，公司已启动并顺利完成了A股股份回购工作。除了通过股票回购保护股东权益外，公司坚信美国国防部依据1260H条款将公司列为“中国军工企业”的决定是错误的，缺乏事实与法律依据。公司已迅速启动法律程序，于6月11日在美国提起诉讼，正式请求法院撤销该决定并将公司从相关名单中移除。","market":"fut","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://stock.stockstar.com/RB2026063000030769.shtml","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"stockstar","symbols":["LU1046422090.SGD","LU1303224171.USD","BK1141","LU2488822045.USD","LU0348766576.USD","02359","BK0216","159982","LU1997245177.USD","LU0320764599.SGD","LU2495084118.USD","IE00BPRC5H50.USD","IE00B543WZ88.USD","BK1583","LU1997244956.HKD","LU1979443071.USD","LU2045819591.USD","LU1251922891.USD","IE00B5MMRT66.SGD","LU0456842615.SGD","LU0348767384.USD","LU1719994722.HKD","LU1997245094.SGD","LU2328871848.SGD","603259","LU1969619763.USD","LU2242644610.SGD","399300","LU1934453819.USD","BK1576","LU1770034418.SGD","LU0052750758.USD","LU2125910500.SGD","LU0708995583.HKD","LU1808992512.USD"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2647535683","title":"智通AH统计|6月30日","url":"https://stock-news.laohu8.com/highlight/detail?id=2647535683","media":"智通财经","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2647535683?lang=zh_cn&edition=full","pubTime":"2026-06-30 16:15","pubTimestamp":1782807306,"startTime":"0","endTime":"0","summary":"智通财经APP获悉，截止6月30日收盘，东北电气、浙江世宝、安德利果汁分列AH溢价率前三位，溢价率分别为864.29%、377.31%、360.00%；宁德时代、兆易创新、招商银行分列AH溢价率末三位，溢价率分别为-32.94%、-16.32%、-5.34%。其中东北电气、安德利果汁、龙蟠科技的偏离值位居前三，分别为136.07%、77.52%、56.51%；另外，弘业期货、新天绿色能源、秦港股份的偏离值位居后三，分别为-30.84%、-24.60%、-16.67%。","market":"fut","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"http://www.zhitongcaijing.com/content/detail/1461093.html","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"stock_zhitongcaijing","symbols":["02701","00042","EWH","399300","00895","00719","06936","03143","03968","LU2242644610.SGD","01088","03750","LU2045819591.USD","SG9999006597.SGD","01108","09989","02338","159982","00916","01276","02208","06031","03296","01057","01138","LU0049853897.USD","00956","02218","LU0359201612.USD","01033","01349","LU0359202008.SGD","BK1151","02865","02359","03200","LU0737861772.HKD","03986","00300","01081","02899","00390","00991","02691","03369","03678","LU0823426480.USD","00588","02465"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2647848581","title":"大摩：升药明康德(02359.HK)目标价至168港元 重申首选股","url":"https://stock-news.laohu8.com/highlight/detail?id=2647848581","media":"智通财经","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2647848581?lang=zh_cn&edition=full","pubTime":"2026-06-30 10:58","pubTimestamp":1782788300,"startTime":"0","endTime":"0","summary":null,"market":"hk","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://www.zhitongcaijing.com/immediately.html?type=ganggu","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"live_zhitongcaijing","symbols":["LU0052750758.USD","LU0708995583.HKD","LU2045819591.USD","BK1576","LU2125910500.SGD","LU1046422090.SGD","LU2242644610.SGD","LU0348766576.USD","BK1141","02359","BK1583","LU0348767384.USD","LU0320764599.SGD"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2647581810","title":"大摩：升药明康德(02359)目标价至168港元 重申首选股","url":"https://stock-news.laohu8.com/highlight/detail?id=2647581810","media":"智通财经","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2647581810?lang=zh_cn&edition=full","pubTime":"2026-06-30 10:58","pubTimestamp":1782788300,"startTime":"0","endTime":"0","summary":"智通财经APP获悉，摩根士丹利发布研报称，将药明康德H股目标价由155港元上调至168港元，重申为其“首选股”，评级维持“增持”; 药明康德A股目标价亦由145元人民币上调至153元人民币，评级维持“增持”。摩根士丹利将药明康德2026至2028年的调整后盈利预测上调4%至6%，这意味着2025至2028年预测的年复合增长率达16%。该行预期药明康德的强劲表现将在2026年和2027年得以持续，且未来有可能会上调全年业绩指引。","market":"hk","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":["rate"],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"http://www.zhitongcaijing.com/content/detail/1460970.html","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"stock_zhitongcaijing","symbols":["02359","EWH","603259"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"1124500168","title":"异动解读｜药明康德盘中上涨3.27%，双回购计划完成叠加机构首次覆盖给予买入评级","url":"https://stock-news.laohu8.com/highlight/detail?id=1124500168","media":"行情直击","labels":["shareholding","buyback"],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/1124500168?lang=zh_cn&edition=full","pubTime":"2026-06-30 09:45","pubTimestamp":1782783928,"startTime":"0","endTime":"0","summary":"6月30日，药明康德盘中上涨3.27%，报157.8港元，成交额2.07亿港元。消息面上，公司公告两项股票回购工作均已实施完毕，包括10亿元A股回购计划（累计回购970.12万股）及25亿港元H股奖励信托计划项下购回（累计购回约2015万股H股）。同时，国金证券首次覆盖公司并给予\"买入\"评级，目标价146.03元，认为CDMO赛道景气度加速上行，Tides业务处于快速放量期。此外，CXO板块延续强势，同业药明合联涨1.46%、药明生物涨0.45%，板块情绪持续升温。（以上内容均基于市场公开消息，由程序或算法智能生成，仅作为股价异动提醒，不作为投资建议或交易依据。）","market":"hk","thumbnail":"","type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"shareholding,buyback","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["02359"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2647227793","title":"药明康德：两项股票回购工作均已实施完毕","url":"https://stock-news.laohu8.com/highlight/detail?id=2647227793","media":"证券之星","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2647227793?lang=zh_cn&edition=full","pubTime":"2026-06-29 16:57","pubTimestamp":1782723454,"startTime":"0","endTime":"0","summary":"证券之星消息，药明康德06月29日在投资者关系平台上答复投资者关心的问题。希望管理层加速回购进度，抓紧低位时段加大回购力度，展现公司对自身价值的认可，提振市场信心，请转交董事会。自5月起，公司已启动2026年度H股奖励信托计划下的H股购回工作。截至目前，两项股票回购工作均已实施完毕，具体请见相应公告。","market":"sh","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://stock.stockstar.com/RB2026062900025024.shtml","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"stockstar","symbols":["LU1046422090.SGD","LU1969619763.USD","LU2125910500.SGD","LU2328871848.SGD","LU2488822045.USD","BK1576","LU0052750758.USD","LU0456842615.SGD","LU0348767384.USD","LU1770034418.SGD","LU2045819591.USD","LU1997245094.SGD","603259","IE00B543WZ88.USD","LU0348766576.USD","LU1719994722.HKD","LU1997244956.HKD","LU0320764599.SGD","02359","LU0708995583.HKD","LU2495084118.USD","LU2242644610.SGD","LU1997245177.USD","LU1251922891.USD","IE00BPRC5H50.USD","BK1583","LU1979443071.USD","LU1934453819.USD","LU1303224171.USD","LU1808992512.USD","BK1141","IE00B5MMRT66.SGD","BK0216"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2647324172","title":"6月29日药明康德涨6.76%，医药ETF易方达基金重仓该股","url":"https://stock-news.laohu8.com/highlight/detail?id=2647324172","media":"证券之星","labels":["shareholding"],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2647324172?lang=zh_cn&edition=full","pubTime":"2026-06-29 16:32","pubTimestamp":1782721967,"startTime":"0","endTime":"0","summary":"证券之星消息，6月29日药明康德涨6.76%创60日新高，收盘报126.17元，换手率4.17%，成交量103.05万手，成交额127.44亿元。根据2026基金Q1季报公募基金重仓股数据，重仓该股的公募基金共629家，其中持有数量最多的公募基金为易方达基金的医药ETF易方达。医药ETF易方达目前规模为172.15亿元，最新净值0.3346，较上一交易日下跌1.88%，近一年下跌8.33%。医药ETF易方达的前十大重仓股如下：以上内容为证券之星据公开信息整理，仅供参考不构成投资建议。","market":"fut","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://stock.stockstar.com/RB2026062900024269.shtml","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"shareholding","news_rank":0,"length":0,"strategy_id":0,"source":"stockstar","symbols":["LU1997245177.USD","LU2242644610.SGD","LU2045819591.USD","LU2125910500.SGD","LU0348766576.USD","IE00B543WZ88.USD","LU0320764599.SGD","LU1719994722.HKD","LU1770034418.SGD","LU1046422090.SGD","LU1979443071.USD","LU0708995583.HKD","LU1969619763.USD","LU1303224171.USD","603259","LU0348767384.USD","BK1583","LU0456842615.SGD","LU2488822045.USD","BK0216","BK1576","LU1997244956.HKD","LU1997245094.SGD","LU1251922891.USD","02359","512010","LU2328871848.SGD","LU1808992512.USD","IE00BPRC5H50.USD","BK1141","LU1934453819.USD","LU0052750758.USD","LU2495084118.USD","IE00B5MMRT66.SGD"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2647325211","title":"港股异动 | CRO概念股涨幅居前 长期看AI将引发行业变革 研发端或分化而生产端整体受益","url":"https://stock-news.laohu8.com/highlight/detail?id=2647325211","media":"智通财经","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2647325211?lang=zh_cn&edition=full","pubTime":"2026-06-29 14:28","pubTimestamp":1782714533,"startTime":"0","endTime":"0","summary":null,"market":"hk","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://www.zhitongcaijing.com/immediately.html?type=ganggu","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"live_zhitongcaijing","symbols":["LU0516423174.USD","LU1242518857.USD","LU1794554557.SGD","LU0039217434.USD","LU0140636845.USD","IE00B0JY6N72.USD","LU0823426308.USD","BK1589","LU0052750758.USD","LU0572944931.SGD","LU0979878070.USD","LU0516422440.USD","LU1046422090.SGD","LU0348766576.USD","LU0819121731.USD","06821","LU0456846285.SGD","02269","LU0516423091.SGD","BK1191","LU0327786744.USD","LU1880383366.USD","LU0359201612.USD","LU0823426480.USD","LU0456827905.SGD","LU0043850808.USD","LU0326950275.SGD","LU0708995583.HKD","LU2242644610.SGD","BK1521","LU3063872942.SGD","LU2039709279.SGD","SG9999002463.SGD","LU0856984785.SGD","BK1583","LU0516422952.EUR","SG9999002562.SGD","LU1720050803.USD","02359","LU0307460666.USD","LU0417516902.SGD","LU0516422366.SGD","LU0588546209.SGD","06127","LU0417516738.SGD","LU2125910500.SGD","LU2045819591.USD","LU0051755006.USD","LU0359202008.SGD","LU1688375341.USD"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2647034208","title":"医药外包概念走强 昭衍新药(06127)涨9.16% 机构指相关标的业绩有望超预期","url":"https://stock-news.laohu8.com/highlight/detail?id=2647034208","media":"金吾财讯","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2647034208?lang=zh_cn&edition=full","pubTime":"2026-06-29 10:20","pubTimestamp":1782699626,"startTime":"0","endTime":"0","summary":"消息面上，东吴证券研究指，22家CXO上市公司2026Q1实现收入、归母净利润、扣非归母净利润总额增速分别同比增长18.6%、21.9%、63.5%，业绩逐季度改善。根据医药魔方，2026Q1，国内创新药一级市场融资总金额25.9亿美元，同比上涨128.6%，2026Q1中国相关交易数量及金额涨势迅猛，总金额达614亿美元，大幅领先国外交易总金额。该机构认为，随着中国创新药在全球研发创新中的比重提升，与其配套的CXO产业链将进一步增强。","market":"sh","thumbnail":"https://static.szfiu.com/news/20241108/ODBhOTU0MzI3NjMwOTM5MjE=.jpg","type":0,"news_type":0,"thumbnails":["https://static.szfiu.com/news/20241108/ODBhOTU0MzI3NjMwOTM5MjE=.jpg"],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"1984678","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["03759","LU1242518931.SGD","LU1720050803.USD","LU1046422090.SGD","LU0588546209.SGD","HK0000320264.USD","LU0348735423.USD","LU1794554557.SGD","BK1141","BK0216","01548","02359","LU0348766576.USD","LU0320764599.SGD","LU0823426308.USD","BK1574","LU0140636845.USD","HK0000306701.USD","LU0417516902.SGD","BK1191","603127","HK0000320223.HKD","09939","BK1583","LU0359202008.SGD","LU0417516738.SGD","LU2045819591.USD","02269","HK0000306685.HKD","LU0348767384.USD","LU0456846285.SGD","LU0348825331.USD","LU3063872942.SGD","06127","159938","LU0516422952.EUR","LU1688375341.USD","LU1880383366.USD","03347","LU2242644610.SGD","LU0181495838.USD","BK1576","LU0326950275.SGD","BK1161","LU0052750758.USD","LU0979878070.USD","LU2125910500.SGD","LU0708995583.HKD","06821","LU0043850808.USD"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"1137179303","title":"异动解读｜药明康德盘中上涨3.51%，机构首次覆盖给予买入评级叠加完成10亿元回购","url":"https://stock-news.laohu8.com/highlight/detail?id=1137179303","media":"行情直击","labels":["shareholding","buyback"],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/1137179303?lang=zh_cn&edition=full","pubTime":"2026-06-29 10:06","pubTimestamp":1782698782,"startTime":"0","endTime":"0","summary":"6月29日，药明康德盘中上涨3.51%，报151.1港元，成交额3.41亿港元。消息面上，国金证券首次覆盖公司并给予\"买入\"评级，目标价146.03元，认为公司CDMO赛道景气度加速上行，Tides业务处于快速放量期，给予25倍PE估值。同时，公司公告已完成10亿元A股股份回购计划，累计回购970.12万股，回购价格区间为95.11元至118.48元，股份将用于员工持股计划。此外，CXO板块今日延续强势，同业康龙化成涨6.47%、药明生物涨4.96%、药明合联涨3.91%，板块情绪持续升温。（以上内容均基于市场公开消息，由程序或算法智能生成，仅作为股价异动提醒，不作为投资建议或交易依据。）","market":"us","thumbnail":"","type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"shareholding,buyback","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["02359"],"isVideo":false,"video":null,"gpt_icon":0}],"profile":{"websiteUrl":"http://www.wuxiapptec.com.cn","stockEarnings":[{"period":"1week","weight":0.017},{"period":"1month","weight":0.249},{"period":"3month","weight":0.2614},{"period":"6month","weight":0.4194},{"period":"1year","weight":0.9785},{"period":"ytd","weight":0.5962}],"compareEarnings":[{"period":"1week","weight":0.0256},{"period":"1month","weight":-0.0539},{"period":"3month","weight":-0.0597},{"period":"6month","weight":-0.1074},{"period":"1year","weight":-0.0125},{"period":"ytd","weight":-0.0786}],"compareStock":{"symbol":"HSI","name":"恒生指数"},"description":"无锡药明康德新药开发股份有限公司是一家主要从事新药研发和生产服务业务的中国公司。该公司主要通过六个分部开展业务。化学业务分部主要从事提供新药研究、开发与生产服务。测试业务分部主要从事提供药品、医疗器械、体外诊断试剂服务。生物学业务分部主要从事提供药物发现及研究服务。高端治疗合同测试、研发与生产（CTDMO）业务分部主要从事为客户提供医疗产品工艺开发、生产和测试一体化服务。国内新药研发服务部分部主要从事为客户提供一体化新药研发服务。其他业务分部主要从事行政服务、销售原材料和销售废料业务。","yearOnYearQuotes":[{"month":1,"riseRate":0.5,"avgChangeRate":0.026729},{"month":2,"riseRate":0.5,"avgChangeRate":0.002975},{"month":3,"riseRate":0.375,"avgChangeRate":-0.010736},{"month":4,"riseRate":0.5,"avgChangeRate":0.006503},{"month":5,"riseRate":0.375,"avgChangeRate":-0.004537},{"month":6,"riseRate":0.75,"avgChangeRate":0.08954},{"month":7,"riseRate":0.75,"avgChangeRate":0.088185},{"month":8,"riseRate":0.571429,"avgChangeRate":0.042301},{"month":9,"riseRate":0.571429,"avgChangeRate":0.088071},{"month":10,"riseRate":0.428571,"avgChangeRate":-0.002332},{"month":11,"riseRate":0.285714,"avgChangeRate":-0.00294},{"month":12,"riseRate":0.571429,"avgChangeRate":0.038239}],"exchange":"SEHK","name":"药明康德","nameEN":"WUXI APPTEC"},"APP":{"userAgent":"Mozilla/5.0 AppleWebKit/537.36 (KHTML, like Gecko; compatible; ClaudeBot/1.0; +claudebot@anthropic.com)","isDev":false,"isTTM":false,"isLaohu8Offline":false,"tenantId":"TBCN","deviceId":"web-server-community-laohu8-v3","version":"4.44.1","shortVersion":"4.44.1","platform":"web","vendor":"web","appName":"laohu8","isIOS":false,"isAndroid":false,"isTiger":false,"isTHS":false,"isWeiXin":false,"isWeiXinMini":false,"isWeiBo":false,"isQQ":false,"isBaiduSwan":false,"isBaiduBox":false,"isDingTalk":false,"isToutiao":false,"isOnePlus":false,"isHuaWei":false,"isXiaomi":false,"isXiaomiWebView":false,"isOppo":false,"isVivo":false,"isSamsung":false,"isMobile":false},"pagemeta":{"title":"药明康德(02359)_个股概要_股票价格_最新资讯_行情走势_历史数据","description":"美港股上老虎。老虎社区提供药明康德(02359)今日价格,行情走势,历史数据,股票概要及实时的新闻资讯,近期大事等重要参考决策数据。","keywords":"药明康德,02359,药明康德股票,药明康德股票老虎,药明康德股票老虎国际,药明康德行情,药明康德股票行情,药明康德股价,药明康德股市,药明康德股票价格,药明康德股票交易,药明康德股票购买,药明康德股票实时行情,购买美股,购买港股,港股开户,美股开户,美股交易,港股交易,开通美港股账户,老虎国际行情","social":{"og_title":"药明康德(02359)_个股概要_股票价格_最新资讯_行情走势_历史数据","og_description":"美港股上老虎。老虎社区提供药明康德(02359)今日价格,行情走势,历史数据,股票概要及实时的新闻资讯,近期大事等重要参考决策数据。","og_image":"https://static.tigerbbs.com/a0b84b8debbbce3b4440f7fdd5eed2e7"}}}